New real-world study demonstrates consistent efficacy and long-term safety of the REN wearable drug-free therapy for over three years of monthly treatment use, offering an alternative to conventional migraine treatment drugs

BRIDGEWATER, N.J. and NETANYA, Israel, Nov. 12, 2025 /PRNewswire/ -- Theranica , a neuromodulation therapeutics company pioneering drug-free treatments for pain conditions, today announced that its latest real-world evidence study has been published in Headache, the official journal of the American Headache Society. The publication, Three years of remote electrical neuromodulation (REN) acute treatment for migraine shows consistent effectiveness and no tachyphylaxis phenomenon , highlights the long-term durability and consistency of the Nerivio® remote electrical

See Full Page